Las Vegas, Nevada, April 27, 2017 -- Praxsyn Corporation (OTCQB: PXYN) is pleased to announce the promotion of Stephanie Kaitz to the position of Financial Controller.
Praxsyn’s Chief Executive Officer, Greg Sundem, commented, “Stephanie has always been a person who can get things done in the office. Stephanie brings a strong cash management skill set to her new role, and is working closely with our auditing firm to finalize our financial reporting and will keep our filings current in the future. I am thrilled to have her on our team and that she made the move to Nevada as we continue to work on efficiencies and a broader sales base. Stephanie will be a key asset in our continued expansion”.
Kimberly Brooks, Praxsyn’s Secretary and General Counsel, commented, “Stephanie has been an integral part of the company for the past three years and has been an amazing employee. She has worked her way up the ladder starting in Data Entry all the way up to Director of Operations for both subsidiaries. It is an honor and a joy to work with her in the company’s new pharmacy endeavor in Las Vegas”.
Stephanie has over 15 years of accounting experience, including acting as an accounting manager at a real estate firm and credit counseling firm. Most recently, Stephanie worked for the company as the Director of Operations for both Mesa Pharmacy, Inc. and Nevada Health Rx, Inc. Stephanie earned a Bachelor’s of Science degree in Business Administration and a Master’s of Arts degree in Management from the University of Redlands in Redlands, California.
Justin Cary is no longer acting in his position as Chief Financial Officer of Praxsyn or any of its subsidiaries, and Stephanie shall take over all of his job duties, including, but not limited to, oversight of the financial reporting, accounts payable and receivable, and cash management.
About Praxsyn Corporation
Headquartered in Las Vegas, Nevada, Praxsyn Corporation is a holding company that finds solutions to fit the needs and goals of medical professionals and their patients. Both Nevada Health Rx and Mesa Pharmacy work to realize the vision of medical professionals to improve the lives of their patients. Additional company information can be found at www.praxsyn.com.
Forward-Looking Statements
Certain statements made in this press release are forward-looking in nature (within the meaning of the Private Securities Litigation Reform Act of 1995) including but not limited to statements in this press release regarding hiring a new financial controller, and thus accordingly, are subject to risks and uncertainties. The actual results may differ materially from those described or contemplated and consequently, you should not rely on these forward-looking statements as predictions of future events. Certain of these risks and uncertainties are discussed in the reports as have been filed with the Securities and Exchange Commission.
Media/Investor Contact: [email protected] 949-777-6112 ext. 101


Nasdaq Proposes Fast-Track Rule to Accelerate Index Inclusion for Major New Listings
TrumpRx Website Launches to Offer Discounted Prescription Drugs for Cash-Paying Americans
CK Hutchison Launches Arbitration After Panama Court Revokes Canal Port Licences
Missouri Judge Dismisses Lawsuit Challenging Starbucks’ Diversity and Inclusion Policies
Uber Ordered to Pay $8.5 Million in Bellwether Sexual Assault Lawsuit
Trump Backs Nexstar–Tegna Merger Amid Shifting U.S. Media Landscape
Hims & Hers Halts Compounded Semaglutide Pill After FDA Warning
Prudential Financial Reports Higher Q4 Profit on Strong Underwriting and Investment Gains
Tencent Shares Slide After WeChat Restricts YuanBao AI Promotional Links
TSMC Eyes 3nm Chip Production in Japan with $17 Billion Kumamoto Investment
Amazon Stock Rebounds After Earnings as $200B Capex Plan Sparks AI Spending Debate
Instagram Outage Disrupts Thousands of U.S. Users
Baidu Approves $5 Billion Share Buyback and Plans First-Ever Dividend in 2026
Weight-Loss Drug Ads Take Over the Super Bowl as Pharma Embraces Direct-to-Consumer Marketing
Washington Post Publisher Will Lewis Steps Down After Layoffs
Alphabet’s Massive AI Spending Surge Signals Confidence in Google’s Growth Engine 



